期刊文献+

Gd-DTPA对胶质瘤磁共振波谱分析的影响研究

Impact of Gd-DTPA on magnetic resonance spectroscopy analysis of glioma
下载PDF
导出
摘要 目的 探讨对比剂Gd-DTPA对颅脑胶质瘤氢质子磁共振波谱的影响.方法 28例脑胶质瘤患者(Ⅲ级间变型星形细胞瘤13例、Ⅳ级胶质母细胞瘤15例),先行MRI平扫,包括T1WI轴位和矢状位扫描、T2WI轴位扫描、T2WI轴位FLAIR扫描.在FLAIR序列上选取肿瘤最大层面,设置感兴趣区进行三位多体素或者单体素氢质子波谱扫描.经肘静脉团注15 ml磁共振对比剂Gd-DTPA后行增强扫描,在肿瘤强化明显后再次行1H-MRS,位置及扫描参数与平扫 MRS完全一致.采用Philips波谱分析软件,比较注射对比剂前后胶质瘤强化区代谢产物NAA、Cr、Cho、NAA/Cr、ChdCr、NAA/Cho值.结果 胶质瘤平扫与增强MRS的瘤体强化区代谢产物NAA、Cr、Cho、NAA/Cr、Cho/Cr、NAA/Cho值分别为(0.20±0.08、0.19±0.09)、(0.24±0.15、0.23±0.15)、(0.51±0.16、0.53±0.17)、(1.02±0.69、0.99±0.63)、(2.76±1.46、2.79±1.51)、(0.41±0.20、0.38±0.17),差异无显著性(P〉0.05).结论 Gd-DTPA对波谱图像无影响,1H-MRS宜在增强扫描后进行,更准确地反映病变区域的代谢物情况. Objective To explore the impact of Gd-DTPA, a contrast agent, on proton magnetic resonance spectroscopy analysis of glioma. Methods MRI scans were performed in 28 patients with glioma ( 13 Ⅲ grade anaplastic astrocytoma and15 Ⅳ grade glioblastoma), includingT1WI axial and sagittal scans,T2WI axial, T2WI axial FLAIR scans. The maximum levels of tumors in the FLAIR sequence were selected as views of interest for three dimension multi-or single-voxel proton spectroscopy scanning. After injection of 15ml of Gd-DTPA, enhanced MRI scans were performed and the level of marked enhancement in tumors were selected. 1H-MRS were performed again, consistent with the plain MRS scans in location and scanning parameters. Philips spectral analysis software was used to compare the values of NAA, Cr, Cho, NAA/Cr,Cho/Cr, and NAA/Cho before and after injertion of contrast agent in enhancement area glioma. Results The values of NAA, Cr, Cho, NAA/Cr, Cho/Cr, and NAA/Cho in plain and enhanced glioma MRS in the lesion enhancement are
出处 《国际医药卫生导报》 2010年第21期2584-2589,共6页 International Medicine and Health Guidance News
基金 江门市科技攻关项目(江科2010[73]-1)
关键词 磁共振波谱分析 增强扫描 对比剂 胶质瘤 Magnetic resonance spectroscopy Enhanced scan Contrast agent Glioma
  • 相关文献

参考文献10

  • 1陈增爱,耿道颖,沈天真,陈星荣,张卫军.质子磁共振波谱对脑肿瘤的鉴别诊断价值[J].中国医学计算机成像杂志,2001,7(4):217-221. 被引量:20
  • 2Robert D,Lai PH,Smith JS.Single voxel proton brain spectroscopy exam (probe/SV) in patients with primary brain tumor[J].AJR,1996,167 (1):201.
  • 3赵京龙,张贵祥.动态增强MR成像在肿瘤血管生成功能成像中的应用[J].中国医学影像技术,2004,20(8):1293-1295. 被引量:7
  • 4Tailor JS,Reddick WE,Kingsley PB,et al.Proton MRS after gadolinium contrast agent[M].Third Scientific Meeting and Exhibition of the Society of Magnetic Resonance.In:Proceeding of the Society of Magnetic Resonance.Nice,France,1995:19-25.
  • 5Fanklyn A,Kirstie S Opstad.1H MR spectroscopy of brain tumors and masses[J].NMR Biomed,2003,16(2):123-131.
  • 6Sijens PE,van den Bent MJ,Nowak PJ,et al.1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast[J].Magn Reson Med,1997,37 (2):222-225.
  • 7Alger JR,Frank JA,Bizzi A,et al.Metabolism of human gliomas:assessment with 1H-MR spectroscopy and F218 fluorodeoxy glucose PET[J].Radiology,1990,177 (2):633-641.
  • 8Smith JK,Kwock L,CastiuoM.Effects of contrast material on single volume proton MR spectroscopy[J].AJNR,2000,21 (6):1084-1089.
  • 9张凯,李传福,刘影,丛培新,郑金勇,冯德朝,孟祥水.对比剂对3 T氢质子MR波谱的影响[J].中华放射学杂志,2006,40(10):1095-1097. 被引量:5
  • 10孟春玲,有慧,冯逢.高场强磁共振系统点分辨波谱技术探讨[J].中国医学影像技术,2005,21(7):1115-1118. 被引量:3

二级参考文献52

  • 1[1]Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging[J]. J Magn Reson Imaging, 2003,17(5):509-520.
  • 2[2]Hanahan D, Folkman J. Patterns and emerging mechanism of the angiogenic switch during tumorigenesis[J]. Cell, 1996,86(3):353-364.
  • 3[3]Dor Y, Porat R, Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis[J]. Am J Physiol Cell Physiol, 2001,280(6):C1367-C1374.
  • 4[4]Dachs GU, Chaplin DJ. Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis[J]. Semin Radiat Oncol, 1998,8(1):208-216.
  • 5[5]Ruohola JK, Valve EM, Karkkainen MJ, et al. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells[J]. Mol Cell Endocrinol, 1999,149(1-2):29-40.
  • 6[6]Gray LH, Conger AD, Ebert M. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor on radiotherapy[J]. Br J Radiol, 1953,26(309):638-648.
  • 7[7]Folkman J. New perspectives in clinical oncology from angiogenesis research[J]. Eur J Cancer, 1996,32(14):2534-2539.
  • 8[8]Rak JW, St Croix BD, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy[J]. Anticancer Drugs, 1995,6(1):3-18.
  • 9[9]Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation[J]. Radiology, 1995,196(2):415-419.
  • 10[10]Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5T[J]. Radiology,1990,176(1):211-220.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部